Navigation Links
Top Washington Health Officials to Honor Framingham Heart Study Participants
Date:11/20/2007

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The nation's top health officials will honor residents of Framingham, Mass., Nov. 29, when they visit the Boston-area community to pay tribute to the thousands of individuals who have participated in the landmark Framingham Heart Study.

HHS Secretary Mike Leavitt, the keynote speaker at an event in Framingham honoring the participants, will discuss a new initiative involving the use of genetic data from the study. This represents the first time a Secretary of HHS has visited a community especially to recognize and express the nation's thanks to those who have taken part in medical research.

Secretary Leavitt will be joined by National Institutes of Health (NIH) Director Elias Zerhouni, M.D., and Elizabeth G. Nabel, M.D., Director of NIH's National Heart, Lung, and Blood Institute (NHLBI), which funds the research, as well as others involved in the study, which is carried out in conjunction with Boston University School of Medicine (BUSM). Dr. Robert Brown, president of Boston University, will also attend.

Invitations to the celebration of the Framingham Heart Study are being sent to more than 9,000 current participants in what is widely considered to be one of the most important epidemiological studies in the history of American medicine. The study is entering its 60th year.

"Our scientific progress in biomedical research depends on the willingness of thousands of Americans to take part in research," Secretary Leavitt said in announcing his visit. "The Framingham Heart Study is a standout example, as it spans three generations and has yielded some of our most important basic knowledge about heart disease. Today, Framingham is poised to make important new contributions based on extensive genetic data from the study."

Genetic information from the Framingham study was recently made available to qualified researchers, in order to advance understanding of the genetic role in heart disease and other conditions. The information is stripped of identifiers to protect the privacy and confidentiality of participants.

"The people of Framingham and vicinity have made an important contribution to the health of our nation and the world, and we are delighted that Secretary Leavitt will recognize that contribution," said BUSM Dean Karen H. Antman, M.D.

Earlier in the day, Secretary Leavitt will address a conference at Harvard Medical School regarding the goals of personalized health care, including the use of genomic information for achieving greater effectiveness in medical treatment.

Additional information about the Framingham Heart Study and its findings is available at http://www.nhlbi.nih.gov/about/framingham/index.html.

Note: All HHS press releases, fact sheets and other press materials are available at http://www.hhs.gov/news.


'/>"/>
SOURCE U.S. Department of Health and Human Services
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Tone Deafness Explained, from the Harvard Health Letter
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... -- The global pacemaker market is expected to reach ... report by Grand View Research, Inc. The heightening prevalence ... coverage is a key driving factor governing the growth ... devices are supporting the expansion of this vertical. ... growth rendering driver for this market. A death estimate ...
(Date:1/16/2017)... , Jan. 16, 2017 Derek H. ... Law Firm, was recently appointed Liaison Counsel in ... for all Xarelto cases. In this role, Potts was ... and will actively assist the Court and Co Lead ... Milstein Adelman Jackson Fairchild & Wade ...
(Date:1/16/2017)...  Harrington Discovery Institute at University Hospitals in ... of The Harrington Project for Discovery & Development ... in collaboration with Alzheimer,s Drug Discovery Foundation (ADDF), ... Harrington Discovery Institute collaborations are ... into new medicines that will improve human health, ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... St. Louisans are well-aware of the following facts at present:, ... influenza shot seems to be having no effect on keeping this particularly bad strain of ... people around are coughing, sneezing, or sniffling , These facts are well-known ...
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon Dr. Mehryar ... official journal of The American Society for Aesthetic Plastic Surgery, in which he ... designed to correct drooping, retracted lower eyelids, which usually result from genetics, injury, ...
(Date:1/16/2017)... ... , ... One thing common to all types of cancer is that it’s ... The money spent screening for and treating cancer in the United States is estimated ... more than in any other country that has an advanced healthcare system, sometimes spending ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... been appointed Chief Executive Officer of the medical device company, effective immediately. , ... Robert Storey. “Kevin has a strong track record in medical device market ...
(Date:1/15/2017)... New York, NY (PRWEB) , ... January 15, 2017 , ... ... growing strategic accounts in the United States for the asthma & allergy friendly mark. ... of America to independently test and identify consumer products to be more suitable for ...
Breaking Medicine News(10 mins):